MacFarlane Lindsey A, Liu Chih-Chin, Solomon Daniel H, Kim Seoyoung C
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA.
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA.
Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):820-6. doi: 10.1002/pds.4044. Epub 2016 May 27.
Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies of gout treatments. We developed and examined the accuracy of a claims-based algorithm to identify gout flares.
Patients receiving care at an academic medical center between 2006 and 2010 with a diagnosis of gout or hyperuricemia were selected using an electronic medical record-Medicare claims linked dataset. Gout flares were identified by several claims-based algorithms using a diagnosis of gout combined with gout-related medication claims and/or procedure codes for arthrocentesis or joint injection. We calculated positive predictive value of these algorithms based on physician documentation of gout flare in medical record as the gold standard. Negative predictive value of the gout flare algorithm was calculated in a randomly selected subgroup of 200 patients with gout.
Among 3952 subjects with gout or hyperuricemia, 503 flares were identified using the medication-based algorithm, and 290 were identified using the procedure-based algorithm. The positive predictive value for gout flares ranged from 50-54% for the medication-based algorithms and 59-68% for the procedure-based algorithms. The negative predictive value of the algorithm combining both medication and procedure claims was high (85.2%).
Use of gout diagnosis codes in combination with medication dispensing or procedure codes did not appear to accurately capture gout flares in patients with gout in a claims database. However, the claims-based flare algorithm could be useful in identifying a cohort of gout patients with no flares. Copyright © 2016 John Wiley & Sons, Ltd.
痛风是一种常见的炎症性关节炎,其特征为反复急性发作。准确识别痛风发作对于痛风治疗的比较疗效研究至关重要。我们开发并检验了一种基于索赔数据的算法来识别痛风发作。
利用电子病历 - 医疗保险索赔链接数据集,选取2006年至2010年间在一家学术医疗中心接受治疗且诊断为痛风或高尿酸血症的患者。通过几种基于索赔数据的算法来识别痛风发作,这些算法采用痛风诊断结合痛风相关药物索赔和/或关节穿刺或关节注射的程序代码。我们以病历中医生记录的痛风发作为金标准,计算这些算法的阳性预测值。在随机选取的200例痛风患者亚组中计算痛风发作算法的阴性预测值。
在3952例痛风或高尿酸血症患者中,基于药物的算法识别出503次发作,基于程序的算法识别出290次发作。基于药物的算法对痛风发作的阳性预测值为50 - 54%,基于程序的算法为59 - 68%。结合药物和程序索赔的算法的阴性预测值较高(85.2%)。
在索赔数据库中,使用痛风诊断代码结合药物配给或程序代码似乎无法准确捕捉痛风患者的痛风发作。然而,基于索赔数据的发作算法可能有助于识别无发作的痛风患者队列。版权所有© 2016约翰威立父子有限公司。